EUVIMEDEUVIMED entdecken
Crossref

Altered gut microbiota, SCFAs, and barrier integrity markers in Alzheimer’s and Parkinson’s disease patients

Somayeh Ahmadi, Alka Hasani iD, Mohammad Yasdchi, Akbar Hasani, Vahdat Poortahmasbe, Farzaneh Rafie Sedaghat, Somaye Kakhki, Safa Najmi, Hammed Hamishehkar

Letters in Applied Microbiology · 04.02.2026 · 79 (2)

DOI: 10.1093/lambio/ovag010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Applied Microbiology, online erschienen am 27.01.2026. Verfasst von Somayeh Ahmadi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Infectious and Tropical Diseases, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614866, Iran. Hauptthemen laut MEDLINE: Parkinson Disease, Alzheimer Disease, Gastrointestinal Microbiome, Dysbiosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Tropical Diseases Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) and Alzheimer’s disease(AD) have significant gut–brain axis interaction via microbial dysbiosis. In this study, Iranian patients with PD (n = 25), ad (n = 25), and neurological disorders (ND, n = 20) were compared with healthy controls (HC, n = 20) in terms of gut microbiota abundance, short-chain fatty acid levels, and gut inflammation markers (calprotectin and zonulin). Stool and blood samples were collected from all participants and analyzed using real-time PCR, high-performance liquid chromatography, and enzyme-linked immunosorbent assay. Significant reductions in Bacteroidetes, Faecalibacterium prausnitzii, Bacteroides spp., Bifidobacterium spp., and Lactobacillus spp. were observed in PD and ad patients versus HC. Enterobacteriaceae levels were elevated in PD, ad, and ND groups, while Proteobacteria were significantly higher only in ND patients. ad patients showed reduced Actinobacteria and increased Akkermansia muciniphila compared to HC. Inflammatory markers calprotectin and zonulin were markedly elevated in all patient groups, indicating intestinal inflammation. These findings suggest that microbial dysbiosis, particularly in PD and ad, may contribute to gut barrier dysfunction and systemic inflammation. Due to sample size and methodological limitations, future studies should incorporate advanced sequencing and longitudinal designs to validate these associations and explore therapeutic implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseAlzheimer DiseaseGastrointestinal MicrobiomeDysbiosisFatty Acids, VolatileHumansMaleBiomarkersFemaleHaptoglobinsAgedFecesMiddle AgedBacteriaProtein PrecursorsIntestinal Barrier FunctionIranCholera ToxinLeukocyte L1 Antigen Complex

Stichwörter der Autor:innen

Alzheimer’s diseaseParkinson’s diseasecalprotectindysbiosisgut microbiotazonulin

Substanzen

zonulinBiomarkersHaptoglobinsFatty Acids, VolatileProtein PrecursorsCholera ToxinLeukocyte L1 Antigen Complex

Autor:innen und Institutionen

  • Research Center of Infectious and Tropical Diseases, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614866, Iran.
  • Department of Bacteriology and Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614866, Iran.
  • Student Research Committee, Tabriz University of Medical Sciences, Tabriz 5166614866, Iran.
  • Clinical Research Development Unit, Sina Educational, Research and Treatment Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614866, Iran.
  • Neurosciences Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614866, Iran.
  • Department of Clinical Biochemistry and Applied Sciences, Tabriz University of Medical Sciences, Tabriz 5166614866, Iran.

ORCID-Profile: Alka Hasani

Förderung

  • Tropical Diseases Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Zitieren

APA

Ahmadi, S., Hasani, A., Yasdchi, M., Hasani, A., Poortahmasbe, V., Sedaghat, F. R., Kakhki, S., Najmi, S., & Hamishehkar, H. (2026). Altered gut microbiota, SCFAs, and barrier integrity markers in Alzheimer’s and Parkinson’s disease patients. Letters in Applied Microbiology, 79(2). https://doi.org/10.1093/lambio/ovag010

Vancouver

Ahmadi S, Hasani A, Yasdchi M, Hasani A, Poortahmasbe V, Sedaghat FR, et al. Altered gut microbiota, SCFAs, and barrier integrity markers in Alzheimer’s and Parkinson’s disease patients. Letters in Applied Microbiology. 2026;79(2). doi:10.1093/lambio/ovag010

BibTeX
@article{Ahmadi2026,
  author = {Ahmadi, Somayeh and Hasani, Alka and Yasdchi, Mohammad and Hasani, Akbar and Poortahmasbe, Vahdat and Sedaghat, Farzaneh Rafie and Kakhki, Somaye and Najmi, Safa and Hamishehkar, Hammed},
  title = {Altered gut microbiota, SCFAs, and barrier integrity markers in Alzheimer’s and Parkinson’s disease patients},
  journal = {Letters in Applied Microbiology},
  year = {2026},
  volume = {79},
  number = {2},
  doi = {10.1093/lambio/ovag010}
}
Kostenlos starten →